“This important acquisition provides our North America organization with a significant foothold in the women’s health space. The acquisition is in line with our stated strategy to enhance our portfolio in our chosen growth markets. We are well-positioned to successfully integrate the portfolio and grow the business,” says Marc Kikuchi, CEO of the company’s North America business.
https://www.pharmalive.com/wp-content/uploads/2023/03/DrR_Logo-2.jpg 500 648 Administrator https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Administrator2023-03-06 10:36:152023-03-06 13:22:27Dr. Reddy's Laboratories announces agreement to acquire Mayne Pharma’s U.S. generic prescription product portfolio